Iterum Therapeutics plc (ITRMF) Other Operating Expenses (2018 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Other Operating Expenses of $369000.0 for Q3 2025, up 107.63% quarter-over-quarter from -$4.8 million in Q2 2025.
Iterum Therapeutics plc (ITRMF) Other Operating Expenses (2018 - 2025) Analysis & Trends
Iterum Therapeutics' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $369000.0 for Q3 2025.
- In Q3 2025, Other Operating Expenses changed N/A year-over-year to $369000.0; the TTM figure through Sep 2025 stood at -$22.3 million (changed N/A YoY), while the FY2024 annual figure was -$18.2 million, changed N/A from the prior year.
- Other Operating Expenses for Q3 2025 stood at $369000.0, up from -$4.8 million in the prior quarter.
- The five-year high for Other Operating Expenses was $369000.0 in Q3 2025, with the low at -$18.2 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 369,000.00 |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | 342,000.00 |
| Dec 31, 2024 | -18.19 Mn |
| Dec 31, 2018 | 1,000.00 |